Furthermore, we found that the increased level of constitutive GAPDH in AD animal models results in aggravation of cognitive deficits and brain pathology linked to AD progression, which can be rescued by a specific GAPDH-targeting small ligand. This evidence concerns the gene GAPDH and Alzheimer disease.